Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study

BACKGROUND AND AIM: Although the treatment effect and availability of therapeutic options for advanced hepatocellular carcinoma (HCC) are limited, the downstaging strategy may improve patient prognosis. This study aimed to investigate the potential of combination therapy as a downstaging strategy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yun, Zhang, Zeyu, Liao, Weijun, Hu, Kuan, Wang, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366058/
https://www.ncbi.nlm.nih.gov/pubmed/34408974
http://dx.doi.org/10.3389/fonc.2021.650394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366058/
https://www.ncbi.nlm.nih.gov/pubmed/34408974
http://dx.doi.org/10.3389/fonc.2021.650394

Ejemplares similares